Procollagen IIA mediates positive feedback control of the mouse cardiogenic transcriptional network
Cardiogenesis relies on the integrated interplay between cardiac transcription factors and signaling pathways. Here, we uncover a role for type IIA procollagen (IIA), an extracellular matrix (ECM) protein encoded by an alternatively spliced <i>Col2a1</i> transcript, encoding a N-terminal cysteine-rich domain, as a critical regulator in a cardiac gene regulatory feedback loop. The cysteine-rich domain of IIA protein was previously reported to interact with bone morphogenetic proteins (BMPs) and transforming growth factors-beta (TGFβ) in in vitro binding assays and acts as a BMP antagonist in amphibian embryo assays. We show that the <i>Col2a1</i> gene in mice is activated in the developing heart by core cardiogenic factors (NKX2-5, GATA4, MEF2, and SRF) via cis-regulatory enhancer elements. IIA loss (ΔIIA) in mice results in depletion of Isl1- and Nkx2-5-expressing progenitors, causing outflow tract defects resembling disrupted BMP/TGFβ-SMAD signaling, alongside reduced nuclear pSMAD1/5/8 in cardiac tissues. Compound <i>+/ΔIIA</i>; <i>Smad4+/-</i> mutants exhibit aggravated malformations. IIA enhances BMP-responsive reporter activity in cells in transactivation assays. We propose that IIA supports a positive functional role on SMAD4-dependent signaling, fine-tuning BMP/TGFβ signaling, thereby regulating GATA4 and NKX2-5 activity during second heart field progenitor specification. These findings position IIA procollagen as a key ECM component that integrates BMP/TGFβ signaling with cardiac transcription factors such as NKX2-5, revealing a feedback loop essential for cardiogenesis. Given its role in cardiac development, IIA emerges as a potential congenital heart disease risk factor.
Authors
- Mirana Ramialison (ORCID: https://orcid.org/0000-0001-6315-4777)
- Owen W.J. Prall (ORCID: https://orcid.org/0000-0003-1600-5933)
- Hieu T. Nim (ORCID: https://orcid.org/0000-0001-9320-0236)
- Sandra Y.Y. Wong
- Kathryn S.E. Cheah (ORCID: https://orcid.org/0000-0003-0802-8799)
- Nelson W. F. Dung
- Alan W. Leung (ORCID: https://orcid.org/0000-0003-3382-7947)
- Timothy J. Mohun (ORCID: https://orcid.org/0000-0002-0216-0417)
- Patrick Tam (ORCID: https://orcid.org/0000-0001-6950-8388)
- Michael See (ORCID: https://orcid.org/0000-0002-7231-3896)
- Danny Tat-Ming Chan (ORCID: https://orcid.org/0000-0003-3824-5778)
- Richard P. Harvey (ORCID: https://orcid.org/0000-0002-9950-9792)
- Janet C. Zhang
- Keith K. H. Leung (ORCID: https://orcid.org/0000-0002-8960-3937)
- Catherine A. Shang (ORCID: https://orcid.org/0000-0002-5116-4668)
Institutions
- The University of Sydney (AU)
- Children's Medical Research Institute (AU)
- Chinese University of Hong Kong (HK)
- Victor Chang Cardiac Research Institute (AU)
- The Francis Crick Institute (GB)
- Australian Regenerative Medicine Institute (AU)
- UNSW Sydney (AU)
- Regenerative Medicine Institute (MX)
- Murdoch Children's Research Institute (AU)
- University of Hong Kong (HK)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1073/pnas.2422592122
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart Foundation of Australia
- Research Grants Council, University Grants Committee
- Novo Nordisk Fonden
- Australian Research Council
- National Health and Medical Research Council